Guangdong Zhongsheng Pharmaceutical Management
Management criteria checks 3/4
Guangdong Zhongsheng Pharmaceutical's CEO is Yong Hong Chen, appointed in Jan 2011, has a tenure of 14.08 years. directly owns 1.62% of the company’s shares, worth CN¥145.52M. The average tenure of the management team and the board of directors is 6.2 years and 5.2 years respectively.
Key information
Yong Hong Chen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14.1yrs |
| CEO ownership | 1.6% |
| Management average tenure | 6.2yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings
Nov 04
Investor Optimism Abounds Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317) But Growth Is Lacking
Oct 07These 4 Measures Indicate That Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Is Using Debt Reasonably Well
Jul 12Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) P/E Is On The Mark
Jun 18Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Has Affirmed Its Dividend Of CN¥0.20
May 20We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings
Apr 29Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?
Mar 18Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Shares Climb 29% But Its Business Is Yet to Catch Up
Feb 29CEO
Yong Hong Chen (53 yo)
14.1yrs
Tenure
CN¥498,700
Compensation
Mr. Yong Hong Chen serves as General Manager of Guangdong Huanan Pharmaceutical Group Co., Ltd. and Guangdong Zhongsheng Pharmaceutical Trade Co., Ltd. Mr. Chen serves as Executive Director of Guangdong Zh...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & President | 14.1yrs | CN¥498.70k | 1.62% CN¥ 145.5m | |
| Vice Chairman & Senior VP | 8.2yrs | CN¥311.50k | 10.95% CN¥ 983.8m | |
| VP, CFO | 15yrs | CN¥372.90k | 0.43% CN¥ 38.3m | |
| VP & Director | 2.2yrs | CN¥372.90k | 0.92% CN¥ 82.5m | |
| Vice President | 6.2yrs | CN¥547.40k | no data | |
| Board Secretary | 1.8yrs | no data | no data | |
| Vice President | 1.1yrs | no data | 0.0012% CN¥ 106.0k |
6.2yrs
Average Tenure
49yo
Average Age
Experienced Management: 002317's management team is seasoned and experienced (6.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & President | 14.1yrs | CN¥498.70k | 1.62% CN¥ 145.5m | |
| Vice Chairman & Senior VP | 8.2yrs | CN¥311.50k | 10.95% CN¥ 983.8m | |
| VP, CFO | 11.1yrs | CN¥372.90k | 0.43% CN¥ 38.3m | |
| VP & Director | 2.2yrs | CN¥372.90k | 0.92% CN¥ 82.5m | |
| Non-Independent Director | 5.2yrs | CN¥72.00k | no data | |
| Non-Independent Director | 8.2yrs | CN¥72.00k | no data | |
| Independent Director | 5.2yrs | CN¥72.00k | no data | |
| Independent Director | 5.2yrs | CN¥72.00k | no data | |
| Supervisor | 8.2yrs | no data | no data | |
| Independent Director | 2.8yrs | CN¥45.00k | no data | |
| Chairman of the Supervisory Board | 2.2yrs | no data | no data | |
| Employee Supervisor | 1.1yrs | no data | no data |
5.2yrs
Average Tenure
53yo
Average Age
Experienced Board: 002317's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/05 15:35 |
| End of Day Share Price | 2025/02/05 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhi Xue Diao | Avic Securities Co., Ltd |
| Shanshan Li | China Merchants Securities Co. Ltd. |
| Sophia Zhang | China Stock Investment Research Co. Ltd. (GZ500..com) |